The Capital Injection: London-based bio-wearable developer Sava Technologies raises $36 million in a Series B round led by Ascensia Diabetes Care, bringing total funding to $68 million to advance clinical trials and scale automated micro-fabrication. The Structural Shift: Sava's sub-dermal microsensors are approximately ten times shorter than conventional CGM sensor filaments. The design aims to reduce the extent of sensor insertion while maintaining continuous glucose mea

Global healthcare is a $12 trillion market carrying a 34-million worker shortage, yet healthtech captured just 5% of the $712 billion in global venture capital deployed in the first half of 2026. That gap, a trillion-dollar industry still treated as a rounding error by the venture industry, is the starting point for everything else here. We at Verge HealthTech Fund have always talked about how healthcare should transform from “sick-care” to “health + care.”

The Valuation Re-Frame: From Consumer Diet Drug to Sovereign Infrastructure Behind closed doors in institutional roundtables and private family office briefings, a fundamental valuation shift has occurred. The early narrative—dominated by direct-to-consumer weight-loss telehealth, consumer hype, and simple scale metrics—has run its course. Institutional allocators are now evaluating incretin receptor agonists through a far more rigorous lens: multi-systemic geroprotective pl

THE HORIZONS Dispatch | Oct - Nov 06 Mapping the future of healthspan capital, brainspan innovation, and luxury infrastructure across Europe, Asia, the Middle East, and beyond.

On the Science, Art, and Soul of Wellness: Healthspan Evolution, Clinical Convergence, and the 20-Year Horizon

At the convergence of geroscience venture capital, private equity roll-ups, and ultra-luxury urban development lies Age-in-Place Longevity Real Estate. By embedding non-invasive diagnostic arrays, adaptive universal design, and invisible healthspan tech directly into private fee-simple units—where average resident retention stretches to 12 to 18 years—these developments de-risk tenant turnover to near-zero churn, boost net operating income by 28% to 42% through high-margin he

Capital follows vitality. Here is where the global longevity, investment, and high-performance ecosystem meets next.

Under the light of Angsana Laguna Phuket, the atmosphere at BEING 2026 felt less like a standard industry gathering and more like a quiet turning point for regional capital. Co-curated by C9 Hotelworks and Delivering Asia, the summit stepped beyond familiar leisure rhetoric to confront a deeper reality unfolding across the island: the fundamental convergence of real estate, clinical medicine, and high-end hospitality.

Exploring Longevity Entrepreneurship, Innovation, and Executive Vitality Complementing this venture-building expertise, Marc is the architect behind the Longevity Investors Conference, the world’s premier private gathering at the intersection of longevity science and capital. While he hosts the exclusive "Longevity Investors Lunch" annually during the World Economic Forum in Davos—a critical platform for high-level dialogue—the flagship Longevity Investors Conference in Gstaa